What is BioCare Diagnostics?
Founded in 1987 by Kenneth Rice, MD, FACC, BioCare Diagnostics, Inc. began as an independent diagnostic imaging facility in Brookline, Massachusetts. Initially offering services such as Cardiac Ultrasound (Echocardiography), Exercise Tolerance Testing, Stress-Echocardiography, Holter monitoring, and event monitoring, the company has since expanded its reach. BioCare Diagnostics now provides essential inpatient and outpatient diagnostic imaging services to numerous area clinics and hospitals, including Braintree Rehabilitation, Spaulding Rehabilitation, Beth Israel Deaconess Hospital-Needham, and Lahey Arlington. The company is committed to delivering high-resolution ultrasound imaging and fostering professional, cooperative relationships with physicians and hospital staff, ensuring high-quality patient care through expert sonographers.
How much funding has BioCare Diagnostics raised?
BioCare Diagnostics has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for BioCare Diagnostics?
The substantial late-stage funding indicates BioCare Diagnostics is poised for significant scaling and strategic expansion. This capital injection will likely be directed towards enhancing technological capabilities, broadening service offerings, and potentially increasing market penetration through new partnerships or acquisitions. The company's focus on high-resolution imaging and strong clinical relationships positions it for continued growth and leadership in the competitive diagnostic services landscape.
See full BioCare Diagnostics company page
